InsiderTrades

Form 4 for IGC IGC Pharma, Inc.

Accepted 2026-04-06 16:02:50 ET · period of report 2026-04-01 · accession 0001185185-26-001286 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-04-06 16:02 2026-04-01 IGC PRINS RICHARD K Dir M - OptEx $0.00 +170.0K 1.54M +12% $0
DM 2026-04-06 16:02 2026-04-01 IGC PRINS RICHARD K Dir M - OptEx $0.00 -170.0K 70.0K -71% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-04-01 M A 100,000 $0.00 1,471,251 D — — (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
2 Common Common Stock 2026-04-01 M A 70,000 $0.00 1,541,251 D — — (F2) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.
3 Derivative Restricted Stock Units 2026-04-01 M D 100,000 $0.00 0 D — · — to — 100,000 Common Stock (F3) Each restricted stock unit represents a right to receive one share of IGC common stock. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. (F1) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
4 Derivative Restricted Stock Units 2026-04-01 M D 70,000 $0.00 70,000 D — · — to — 70,000 Common Stock (F3) Each restricted stock unit represents a right to receive one share of IGC common stock. (F2) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025. (F2) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025. (F2) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025.